Cargando…
Efficient Method for Generating Point Mutations in the Vaccinia Virus Genome Using CRISPR/Cas9
The vaccinia virus (VACV) was previously used as a vaccine for smallpox eradication. Nowadays, recombinant VACVs are developed as vaccine platforms for infectious disease prevention and cancer treatment. The conventional method for genome editing of the VACV is based on homologous recombination, whi...
Autores principales: | Boutin, Laetitia, Mosca, Estelle, Iseni, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321979/ https://www.ncbi.nlm.nih.gov/pubmed/35891539 http://dx.doi.org/10.3390/v14071559 |
Ejemplares similares
-
Selection of Primer–Template Sequences That Bind with Enhanced Affinity to Vaccinia Virus E9 DNA Polymerase
por: DeStefano, Jeffrey J., et al.
Publicado: (2022) -
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9
por: Yuan, Ming, et al.
Publicado: (2015) -
Efficient Generation of Myostatin Gene Mutated Rabbit by CRISPR/Cas9
por: Lv, Qingyan, et al.
Publicado: (2016) -
Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System
por: Wang, Kankan, et al.
Publicado: (2015) -
Rapid generation of mouse models with defined point mutations by the CRISPR/Cas9 system
por: Inui, Masafumi, et al.
Publicado: (2014)